Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Venetoclax Combined With Azacitidine”

132 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 132 results

Testing effectiveness (Phase 2)WithdrawnNCT06085638
What this trial is testing

Phase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Chronic Myelomonocytic Leukemia

Who this might be right for
Chronic Myelomonocytic Leukemia
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Not Yet RecruitingNCT07735117
What this trial is testing

Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AML

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS)
Ruijin Hospital 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT04086264
What this trial is testing

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
AbbVie 218
Not applicableLooking for participantsNCT06386302
What this trial is testing

Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
AMLAcute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 184
Not applicableStudy completedNCT05456048
What this trial is testing

Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML

Who this might be right for
Relapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaGene Abnormality+1 more
Nanfang Hospital, Southern Medical University 231
Early research (Phase 1)Looking for participantsNCT06737523
What this trial is testing

Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML

Who this might be right for
Acute Myeloid LeukemiaRelapseRefractory AML
The First Affiliated Hospital of Xiamen University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06483906
What this trial is testing

Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.

Who this might be right for
Acute Myeloid Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 56
Testing effectiveness (Phase 2)Study completedNCT04267081
What this trial is testing

Study of Venetoclax in Combination With Azacytidine in AML Patients Selected Using Ex Vivo Drug Sensitivity Screening

Who this might be right for
Acute Myeloid Leukemia
Helsinki University Central Hospital 104
Early research (Phase 1)Ended earlyNCT04755244
What this trial is testing

Evorpacept (ALX148) With Venetoclax and Azacitidine for Acute Myeloid Leukemia (ASPEN-05)

Who this might be right for
Acute Myeloid LeukemiaAML, Adult
ALX Oncology Inc. 14
Early research (Phase 1)Active Not RecruitingNCT05001828
What this trial is testing

Study of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia, Adult
Polaris Group 38
Testing effectiveness (Phase 2)Looking for participantsNCT06696183
What this trial is testing

Gilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible for Intensive Treatment

Who this might be right for
AML - Acute Myeloid Leukemia
Technische Universität Dresden 60
Testing effectiveness (Phase 2)Looking for participantsNCT07392242
What this trial is testing

The Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center 45
Not applicableLooking for participantsNCT05587049
What this trial is testing

Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Oral Venetoclax Tablets in Combination With Subcutaneously (SC) or Intravenously (IV) Injected Azacitidine in Colombia

Who this might be right for
Acute Myeloid Leukemia
AbbVie 70
Testing effectiveness (Phase 2)Looking for participantsNCT07007949
What this trial is testing

A New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaIDH1 Gene MutationIvosidenib
The First Affiliated Hospital of Soochow University 42
Testing effectiveness (Phase 2)Looking for participantsNCT07159620
What this trial is testing

Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients

Who this might be right for
Adult T-cell Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University 27
Testing effectiveness (Phase 2)UnknownNCT06532058
What this trial is testing

Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML)
Changzhou Qianhong Bio-pharma Co., Ltd. 53
Post-approval studies (Phase 4)Active Not RecruitingNCT05144243
What this trial is testing

Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 44
Early research (Phase 1)Looking for participantsNCT06372717
What this trial is testing

Investigate APL-4098 Alone and in Combination in Adults With AML or MDS

Who this might be right for
Acute Myeloid Leukemia RefractoryMyelodysplastic Syndrome Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts+2 more
Apollo Therapeutics Ltd 100
Testing effectiveness (Phase 2)Looking for participantsNCT06757855
What this trial is testing

Olverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CML

Who this might be right for
CML,Blast Phase
Institute of Hematology & Blood Diseases Hospital, China 29
Large-scale testing (Phase 3)Not Yet RecruitingNCT07425808
What this trial is testing

FLT3-ITD Targeted Therapy in Fit AML Patients

Who this might be right for
AML (Acute Myeloid Leukemia)
European Organisation for Research and Treatment of Cancer - EORTC 230
Next Page